Text | duration | start | ents | sentiment |
---|---|---|---|---|
the second anti-viral drug along with | 4.08 | Jump to 7.2 |
|
|
19. so now we have vaccines we have | 5.04 | Jump to 13.12 |
|
|
30 | 3.439 | Jump to 95.04 |
|
|
and death if given in that first three | 3.841 | Jump to 98.479 |
|
|
to five days of onset of symptoms | 4.32 | Jump to 100.479 |
|
|
whereas pfizer is close to almost 90 | 4.4 | Jump to 102.32 |
|
|
only approved for 18 and up and not for | 5.28 | Jump to 113.439 |
|
|
whereas pfizer is approved for age 12 | 4.639 | Jump to 126.96 |
|
|
88 pounds but there are some uh | 4.561 | Jump to 131.599 |
|
|
take six pills a day almost three | 5.84 | Jump to 136.16 |
|
|
morning and night for five days and uh | 5.599 | Jump to 138.72 |
|
|
best prepare yourself to battle covet 19 | 4.881 | Jump to 200.239 |
|
|
is still number one prevention is key | 4.961 | Jump to 207.519 |
|
|
even mild and moderate cases of covet 19 | 4.88 | Jump to 212.48 |
|
|
two years later we don't know how long | 4.401 | Jump to 218.959 |
|
|
effect profiles of these two antivirals | 3.92 | Jump to 223.36 |
|
|
hopefully by the winter of 2022 we're | 4.159 | Jump to 264.32 |
|